Literature DB >> 30358835

A simple method to quantify follicle survival in cryopreserved human ovarian tissue.

S G Kristensen1, Q Liu1,2, L S Mamsen1, T Greve1, S E Pors1, A B Bjørn3, E Ernst3,4, K T Macklon5, C Y Andersen1.   

Abstract

STUDY QUESTION: Can follicle survival in frozen-thawed human ovarian tissue be quantified in situ using the dye Neutral Red (NR) to stain viable follicles specifically? SUMMARY ANSWER: A follicle survival rate within ovarian tissue can be calculated using NR followed by histological evaluation and evidence for a consistently high follicle survival in a series of ovarian tissue from 25 Danish girls and women undergoing ovarian tissue cryopreservation (OTC) was obtained. WHAT IS KNOWN ALREADY: Securing follicle survival in cryopreserved ovarian tissue is crucial for proper quality control when centers wish to implement OTC. The only established technique for validation of follicle survival is xenografting of thawed ovarian tissue to immunodeficient mice. However, this functional test is expensive, time consuming, requires animal facilities and only provides a qualitative-not quantitative-measure for follicle survival. STUDY DESIGN SIZE, DURATION: Quantification of follicle survival in human ovarian tissue donated from 30 girls and women having tissue cryopreserved for fertility preservation from 2000 to 2015 at the Laboratory of Reproductive Biology in Copenhagen, Denmark. PARTICIPANTS/MATERIALS, SETTING,
METHODS: Cryopreserved ovarian cortex was donated from 25 girls and young women aged 10-36 years (mean age: 25 years) and the average storage time in liquid nitrogen was 9.1 ± 5.6 years, ranging from 1.6 to 17.9 years. In 12 of the cases, the ovarian tissue was collected from the local hospital and in the other 13 cases the ovarian tissue was transported on ice up to 6 h prior to freezing. Donated fresh ovarian surplus tissue was obtained from five women aged 23-34 years (mean age: 27 years). Ovarian tissues were chopped into small fragments and incubated in culture medium containing 50 mg/ml NR for 3-4 h. Fragments of ovarian tissue containing clearly NR-stained follicles were selected for counting, encapsulated in 4% agar and were processed for histology to calculate a follicular survival rate. MAIN RESULTS AND THE ROLE OF CHANCE: The mean follicle survival rate in the 25 patients after freezing and thawing was 84% ± 11 (mean ±SD), ranging from 50% to 98%. The high follicle survival rate in this clinical series of patients reflects a constant high-quality service performed in our center and confirms the robustness of the slow freezing protocol. No significant association between follicle survival rates and storage time was found using linear regression analysis, suggesting that storage in liquid nitrogen does not affect viability of the tissue. No significant association in follicle survival rates was found between ovarian tissues collected at the local hospital compared to tissues transported on ice prior to freezing, supporting that prolonged cooling does not seem to greatly affect the follicle survival. For the fresh ovarian tissue, the average follicle survival rate was 91% ± 5 (mean ± SD) in five patients, ranging from 81% to 95%. LIMITATIONS, REASONS FOR CAUTION: Even though the NR staining requires active incorporation of the dye, the test is merely a short in situ test that cannot completely replace the functional value of xenografting studies in which the integrity and developmental potential of the ovarian follicles are assessed. WIDER IMPLICATIONS OF THE
FINDINGS: OTC is now being employed around the world but to date it has been difficult for centers to evaluate the effectiveness of their program and perform proper quality control. NR staining combined with histological evaluation is the first quantitative method to provide a survival rate for follicles in frozen-thawed human ovarian tissue and offer a valuable and easily applicable tool to validate the cryopreservation procedure when implementing OTC or as routine quality control for the overall freezing performance within tissue banking facilities. STUDY FUNDING/COMPETING INTEREST(S): The Research Pools of Rigshospitalet, the Danish Cancer Foundation, Dagmar Marshalls Foundation, and the Novo Nordic Foundation are thanked for having funded this study. The authors have no conflicts of interest.

Entities:  

Mesh:

Year:  2018        PMID: 30358835     DOI: 10.1093/humrep/dey318

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  12 in total

1.  Hormonal response in patients transplanted with cryopreserved ovarian tissue is independent of whether freezing was performed in childhood or adulthood.

Authors:  V Greve Hornshøj; M Dueholm; L S Mamsen; E Ernst; C Y Andersen
Journal:  J Assist Reprod Genet       Date:  2021-10-06       Impact factor: 3.412

2.  Effects of Er:YAG laser treatment on re-vascularization and follicle survival in frozen/thawed human ovarian cortex transplanted to immunodeficient mice.

Authors:  Linn Salto Mamsen; Hanna Ørnes Olesen; Susanne Elisabeth Pors; Xiaohui Hu; Peter Bjerring; Kåre Christiansen; Cristina Subiran Adrados; Claus Yding Andersen; Stine Gry Kristensen
Journal:  J Assist Reprod Genet       Date:  2021-08-27       Impact factor: 3.357

3.  Lack of Knowledge, the main Stumbling Block of Fertility Preservation Promotion in China.

Authors:  Meng Wang; Lixia Zhu; Hua Xiong; Jiaming Wang; Zhou Li; Liu Yang; Lei Jin; Qingsong Xi
Journal:  J Cancer Educ       Date:  2020-09-12       Impact factor: 1.771

4.  Fresh and cryopreserved ovarian tissue from deceased young donors yields viable follicles.

Authors:  Yuting Fan; Colleen L Flanagan; Margaret A Brunette; Andrea S Jones; Brendon M Baker; Sherman J Silber; Ariella Shikanov
Journal:  F S Sci       Date:  2021-06-10

5.  MYO10 promotes transzonal projection-dependent germ line-somatic contact during mammalian folliculogenesis†.

Authors:  Sofia Granados-Aparici; Alexander Volodarsky-Perel; Qin Yang; Sibat Anam; Togas Tulandi; William Buckett; Weon-Young Son; Grace Younes; Jin-Tae Chung; Shaoguang Jin; Marie-Emilie Terret; Hugh J Clarke
Journal:  Biol Reprod       Date:  2022-08-09       Impact factor: 4.161

6.  Ovarian tissue cryopreservation and novel bioengineering approaches for fertility preservation.

Authors:  Andrea S K Jones; Ariella Shikanov
Journal:  Curr Breast Cancer Rep       Date:  2020-11-04

7.  Intrafollicular Concentrations of the Oocyte-secreted Factors GDF9 and BMP15 Vary Inversely in Polycystic Ovaries.

Authors:  Stine Gry Kristensen; Ajay Kumar; Linn Salto Mamsen; Bhanu Kalra; Susanne Elisabeth Pors; Jane Alrø Bøtkjær; Kirsten Tryde Macklon; Jens Fedder; Erik Ernst; Kate Hardy; Stephen Franks; Claus Yding Andersen
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

Review 8.  FertiPROTEKT, Oncofertility Consortium and the Danish Fertility-Preservation Networks - What Can We Learn From Their Experiences?

Authors:  Michael von Wolff; Claus Yding Andersen; Teresa K Woodruff; Frank Nawroth
Journal:  Clin Med Insights Reprod Health       Date:  2019-04-30

9.  Single-cell analysis of human ovarian cortex identifies distinct cell populations but no oogonial stem cells.

Authors:  Fredrik Lanner; Pauliina Damdimopoulou; Magdalena Wagner; Masahito Yoshihara; Iyadh Douagi; Anastasios Damdimopoulos; Sarita Panula; Sophie Petropoulos; Haojiang Lu; Karin Pettersson; Kerstin Palm; Shintaro Katayama; Outi Hovatta; Juha Kere
Journal:  Nat Commun       Date:  2020-03-02       Impact factor: 14.919

10.  Slow-Freezing Cryopreservation Ensures High Ovarian Tissue Quality Followed by In Vivo and In Vitro Methods and Is Safe for Fertility Preservation.

Authors:  Živilė Gudlevičienė; Kastytis Žilinskas; Gabrielis Kundrotas; Monika Grubliauskaitė; Daiva Baltriukienė; Virginija Bukelskienė
Journal:  Medicina (Kaunas)       Date:  2020-10-19       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.